Stronger Warnings on ADHD Drugs

An advisory panel to the U.S. Food & Drug Administration has voted by a narrow majority to add a ‘black box’ warning to methylphenidates such as Ritalin, Concerta, Methylin and Metadate. This follows the deaths of 19 children and six adults being linked to the drugs which are used by over 2 million children a year. Currently Adderall has a warning telling patients with heart conditions not to use the drug and Strattera has a black-box warning that it may prompt suicidal thoughts in children.
Drug Safety and Risk Management Advisory Committee, FDA Panel Calls for Strongest Warning on ADHD Drugs
Previously on Myomancy: Strattera Suicide Risk, Are ADHD drugs safe?, Adderall: Benefits and Side-Effects, FDA Concerns Over ADHD Drug Concerta

Search Myomancy for news and information about ADHD, Dyslexia and Autism including diagnosis techniques, treatments and the science behind them.

A comprehensive list of every type of treatment available for ADHD, Autism and Dyslexia reviewed and rated by people who have tried them is available on the Myomancy Treatment Database. It covers mainstream treatments focusing on Reading as well as those less recognised using Biofeedback, Dietry and Rhythm. There are also treatments that deal with specific issues such as Audiotory, Visual, Balance, Coordination, Memory. Some treatments are provided as special centers whilst others are available via Books, CDs, DVDs or Software.

Read the latest on ADHD, Dyslexia and Autism from Myomancy via RSS 2.0 or use FeedBurner:

Myomancy ADHD, Dyslexia and Autism